Register Login

Olema Oncology (OLMA)

Kovacs Shane William Charles 🔴 sold 103.8K shares of Olema Pharmaceuticals, Inc. (OLMA) at $28.73 ($3.0M) Transaction Date: Jan 13, 2026 | Filing ID: 000002

Full text
Register to leave comments
  • News bot Jan. 29, 2026, 2:25 p.m.

    🔍 Kovacs Shane William Charles (Executive)

    Company: Olema Pharmaceuticals, Inc. (OLMA)

    Report Date: 2026-01-13

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 103,822

    Detailed Transactions and Holdings:

    • Sold 3,822 shares of Common Stock at $28.01 per share (Direct)
      Date: 2026-01-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 239,727.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 100,000 shares of Common Stock at $28.73 per share (Direct)
      Date: 2026-01-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 139,727.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: The weighted average sale price for the transaction reported was $28.01, and the range of prices were between $28.00 and $28.03. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
    • F2: The weighted average purchase price for the transaction reported was $28.73, and the range of prices were between $28.50 and $29.18. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price will be provided.

Search

News categories